Navigation Links
BIDMC's Peter Weller, M.D., receives NIH MERIT Award
Date:4/27/2011

BOSTON -- Peter Weller, MD, Chief of both the Division of Allergy and Inflammation and the Division of Infectious Diseases at Beth Israel Deaconess Medical Center (BIDMC), is the recipient of an NIH MERIT award from the National Institute of Allergy and Infectious Diseases. A Professor of Medicine at Harvard Medical School, Weller received the award for his longstanding grant, "Human Eosinophils: Mechanisms of Functioning."

An acronym for the Method to Extend Research in Time, MERIT Awards are intended to provide long-term research grant support to scientists who have demonstrated a stellar record of research accomplishment. Rather than being awarded through an application process, MERIT awards are given at the discretion of the NIH, with fewer than five percent of investigators selected as MERIT recipients.

"This is particularly rewarding because this was the first grant my laboratory received when I joined the former Beth Israel Hospital 27 years ago," says Weller. "Over nearly three decades, our studies and those of others have peeled away the onion skin surrounding eosinophils to show that they are not so simple as once thought. This MERIT award will assure the funding to continue this work."

Eosinophils are one of five major types of white blood cells. Eosinophils serve roles in the body's immune system, but the functions of eosinophils are still poorly understood.

"Higher-than-normal levels of eosinophils ecome problematic," explains Weller. This can occur when too many of the cells are recruited to a disease site or when the bone marrow overproduces eosinophils. Parasitic diseases, asthma and allergic reactions are among the more common causes of eosinophilia, the term used to describe high levels of eosinophils.

Weller's laboratory, in collaboration with the laboratory of Ann Dvorak, MD, a scientist in BIDMC's Department of Pathology, has greatly expanded the understanding of these white blood cells. In particular, their research has illuminated the role of eosinophils as granulocytes, cells containing preformed granules. The granules of eosinophils contain many proteins called cytokines that act to affect other cells. In eosinophils cytokines are already formed and can be released both from granules within eosinophils and also from granules that are present outside the cells.

In addition, work out of the Weller laboratory has helped to inform the clinical management of eosinophilic disorders and pointed to potential treatments for eosinophil-related diseases. In 2007, BIDMC's Division of Allergy and Inflammation developed the Center for Eosinophilic Disorders, an interdisciplinary program for the evaluation and management of these conditions. Javed Sheikh, MD, is the clinical Director of the Center.

"BIDMC is one of only a few national institutions with established expertise in the research and treatment of eosinophil-associated diseases," explains Weller. "Both ongoing NIH-funded basic research of eosinophils as well as clinically oriented studies that help us understand the roles of these white blood cells in disease have distinguished us in this field, and the eosinophil-focused programs at BIDMC have benefited from the sustained contributions of both research investigators and trainees and of expert clinicians."


'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Related medicine news :

1. Multi-Award Winning Author Tina Turbin Interviews Special Guest Dr. Peter H.R. Green, M.D. On The Thrive in Balance Radio Show
2. Peter Harker Joins Prometheus Research as Vice President of Sales
3. Truth-O-Meter™ Comes to Florida: St. Petersburg Times, The Miami Herald Launch PolitiFact Florida
4. Florida, St. Petersburg Lead National Cremation Trend
5. Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room
6. Peter Shizgal distinguished by his peers
7. AMA Honors Vice Admiral John Mateczun, M.D., With Top Government Service Award
8. Nationally Known Interventional Neuroradiologist John Pile-Spellman, M.D., Joins Neurological Surgery, P.C.
9. University of Utah afib specialist, Marcos Daccarett, M.D., wins Young Investigator Award
10. Joan Miller, M.D., receives 2010 Leadership Award for the Advancement of Women Faculty
11. Gino Tutera, M.D., F.A.C.O.G. Brings SottoPelle Therapy to Middle Tennessee, Opens Practice in Nashville Medical District
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Technology™, is the first technology to directly address the resolution to globally reduce ... Technology™ is a patented compound of FDA and TTB approved ingredients that when ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, ... be invited to the Siemens Healthineers annual customer education symposium, a world-class learning ... take place from March 27 - 31, 2017 at the Atlanta Marriott Marquis ...
(Date:3/28/2017)... ... 2017 , ... The Thyroid Secret is a specialized 9-part ... program was recently launched on March 1, and Dr. Wentz discussed varied benefits ... Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. After ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... share of all holidays (IBT World Travel Trends Report). As travelers visit both ... a range in temperatures, and prolonged sun exposure. In response, the outdoor industry ...
(Date:3/28/2017)... San Mateo, CA (PRWEB) , ... ... ... Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science ... manuscript leveraging data from its RSSearch Patient Registry, a multi-institutional, observational registry ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... NEW YORK , March 29, 2017 ... ... society and the public safety in regulating marijuana, but economic ... revenues, job creation, and reduced law enforcement costs. However, to ... like those provided by SinglePoint, Inc. (OTC: SING) ( SING ...
(Date:3/29/2017)... , March 29, 2017 Neurim Pharmaceuticals ... Exeltis will obtain exclusive marketing rights for Neurim,s new Rx PedPRM ... ... targeted to treat sleep disorders in children with Autism Spectrum Disorders ... sleep medication approved for children. The collaboration with Exeltis ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ... release financial results for the year ended December ... 26, 2017. The results are being released later ... financial statements will include the operations and balances ... 1, 2016.  This release and filing date meets ...
Breaking Medicine Technology: